日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expandable Nanocomposite Shape-Memory Hemostat for the Treatment of Noncompressible Hemorrhage

用于治疗不可压迫性出血的可膨胀纳米复合材料形状记忆止血剂

Biswas, Saptarshi; Miller, Sarah E; Roy, Shounak; Thazhaiselvam, Jeevika; Foster, Samantha; Kalairaj, Manivannan Sivaperuman; George, Sasha M; Jones-Hall, Yava; Horn, Staci J; Clubb, Fred J; Ware, Taylor H; Maitland, Duncan J; Gaharwar, Akhilesh K

Native Mass Spectrometry-Based Proteomics Reveals the Mechanism of Hemophore Release by Pathogenic Corynebacterium diphtheriae

基于天然质谱的蛋白质组学揭示了致病性白喉棒状杆菌释放血红素的机制

Goring, Andrew K; Lyman, Lindsey R; Ford, Jordan; Huang, Jingjing; Mullen, Christopher; Melani, Rafael D; Schmitt, Michael P; Clubb, Robert T; Loo, Joseph A

Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma

纵向液体活检可识别头颈部鳞状细胞癌免疫检查点阻断反应的早期预测性生物标志物

Wang, Binbin; Saddawi-Konefka, Robert; Clubb, Lauren M; Tang, Shiqi; Wu, Di; Mukherjee, Sumit; Sahni, Sahil; Dhruba, Saugato Rahman; Yang, Xinping; Patiyal, Sumeet; Day, Chi-Ping; Desai, Parth A; Allen, Clint; Wang, Kun; Gutkind, J Silvio; Ruppin, Eytan

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

溶瘤腺病毒 TILT-123 与派姆单抗联合治疗铂类耐药或难治性卵巢癌:1a 期 PROTA 试验

Matthew Stephen Block #, James Hugo Armstrong Clubb #, Johanna Mäenpää, Santeri Pakola, Dafne Carolina Alves Quixabeira, Tatiana Kudling, Elise Jirovec, Lyna Haybout, Mirte van der Heijden, Sanae Zahraoui, Susanna Grönberg-Vähä-Koskela, Sini Raatikainen, Victor Arias, Saru Basnet, Nea Ojala, Teijo P

YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution

YAP 驱动的口腔上皮干细胞恶性重编程(单细胞分辨率)

Farhoud Faraji, Sydney I Ramirez, Lauren M Clubb, Kuniaki Sato, Valeria Burghi, Thomas S Hoang, Adam Officer, Paola Y Anguiano Quiroz, William M G Galloway, Zbigniew Mikulski, Kate Medetgul-Ernar, Pauline Marangoni, Kyle B Jones, Yuwei Cao, Alfredo A Molinolo, Kenneth Kim, Kanako Sakaguchi, Joseph A

The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy

肿瘤前哨淋巴结免疫迁移组学分析表明,CCR7⁺树突状细胞驱动对序贯免疫放射疗法的反应。

Robert Saddawi-Konefka ,Riyam Al Msari ,Shiqi Tang ,Chad Philips ,Sayed Sadat ,Lauren M Clubb ,Sarah Luna ,Santiago Fassardi ,Riley Jones ,Ida Franiak Pietryga ,Farhoud Faraji ,Shiruyeh Schokrpur ,Bryan S Yung ,Michael M Allevato ,Kelsey E Decker ,Chanond A Nasamran ,Daisy Chilin-Fuentes ,Sara Brin Rosenthal ,Shawn M Jensen ,Bernard A Fox ,R Bryan Bell ,J Silvio Gutkind ,Andrew Sharabi ,Joseph A Califano

Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma

肿瘤浸润淋巴细胞联合溶瘤腺病毒TILT-123治疗转移性黑色素瘤的安全性和有效性

Tine J Monberg,Santeri A Pakola,Benedetta Albieri,Eva Ellebaek,Marco Donia,Rikke L Eefsen,Troels H Borch,Tatiana V Kudling,Torben Lorentzen,Helle W Hendel,Cecilie Vestergaard,Cathrine Lorentzen,Rikke B Holmstroem,Victor Arias,Amir Khammari,Claudia Kistler,João M Santos,James H A Clubb,Lyna Haybout,Marie C W Westergaard,Özcan Met,Dafne C A Quixabeira,Elise Jirovec,Riikka Havunen,Suvi Sorsa,Victor Cervera-Carrascon,Brigitte Dreno,Akseli Hemminki,Inge Marie Svane  0

Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma

肿瘤浸润淋巴细胞联合溶瘤腺病毒TILT-123治疗转移性黑色素瘤的安全性和有效性

Tine J Monberg ,Santeri A Pakola ,Benedetta Albieri ,Eva Ellebaek ,Marco Donia ,Rikke L Eefsen ,Troels H Borch ,Tatiana V Kudling ,Torben Lorentzen ,Helle W Hendel ,Cecilie Vestergaard ,Cathrine Lorentzen ,Rikke B Holmstroem ,Victor Arias ,Amir Khammari ,Claudia Kistler ,João M Santos ,James H A Clubb ,Lyna Haybout ,Marie C W Westergaard ,Özcan Met ,Dafne C A Quixabeira ,Elise Jirovec ,Riikka Havunen ,Suvi Sorsa ,Victor Cervera-Carrascon ,Brigitte Dreno ,Akseli Hemminki ,Inge Marie Svane

Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

短暂性淋巴细胞计数下降与溶瘤腺病毒在人体内的疗效相关:来自 TUNIMO I 期试验的机制和生物标志物发现

Santeri A Pakola ,James H A Clubb ,Tatiana V Kudling ,Mirte van der Heijden ,Elise Jirovec ,Victor Arias ,Lyna Haybout ,Katriina Peltola ,Tuomo Alanko ,Jorma Sormunen ,Teijo Pellinen ,Kristian Taipale ,Dafne C A Quixabeira ,Claudia Kistler ,Riikka Havunen ,Suvi Sorsa ,Joao M Santos ,Victor Cervera-Carrascon ,Akseli Hemminki

Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

短暂性淋巴细胞计数下降与溶瘤腺病毒在人体内的疗效相关:来自 TUNIMO I 期试验的机制和生物标志物发现

Santeri A Pakola,James H A Clubb,Tatiana V Kudling,Mirte van der Heijden,Elise Jirovec,Victor Arias,Lyna Haybout,Katriina Peltola,Tuomo Alanko,Jorma Sormunen,Teijo Pellinen,Kristian Taipale,Dafne C A Quixabeira,Claudia Kistler,Riikka Havunen,Suvi Sorsa,Joao M Santos,Victor Cervera-Carrascon,Akseli Hemminki